US biopharma: "nearly 300 vaccines in R&D"

Article Date: 24/04/2012 06:00
US biopharma: "nearly 300 vaccines in R&D"

Vacancy Search

Quick job search

Advanced Search

Latest News

Omeros hit by Huntington's trial suspension

Omeros hit by Huntington's trial suspension

Shareholder asks Amgen to split into two businesses

Shareholder asks Amgen to split into two businesses

BI's nintedanib in PhIII for colorectal cancer

BI's nintedanib in PhIII for colorectal cancer

FDA will review Lilly/BI diabetes combo

FDA will review Lilly/BI diabetes combo

Number of cancer nurses hits high but more needed

Number of cancer nurses hits high but more needed

Unanimous FDA panel support for Novartis' secukinumab

Unanimous FDA panel support for Novartis' secukinumab

Shire bullish as AbbVie deal breathes its last

Shire bullish as AbbVie deal breathes its last

CR UK offers £10m to support biological therapies

CR UK offers £10m to support biological therapies

Celgene oral Crohn's drug impresses in Phase II

Celgene oral Crohn's drug impresses in Phase II

SBRI initiative offers another £2.5m for SMEs

SBRI initiative offers another £2.5m for SMEs
more news